معرفی
Celine Bouvy is an active Researcher at the University of Namur, specializing in hematology and clinical pharmacology. She contributes significantly to the Clinical Pharmacology Research Group and the COVILAB project (focused on COVID-19 laboratory investigations), working alongside supervisors including Jean-Michel Dogné and Jonathan Douxfils.
Her doctoral research culminated in a 2017 PhD thesis titled Roles of extracellular vesicles and their microRNA cargo in chemotherapeutic resistance, pro-coagulant phenotype and as potential biomarkers in diffuse large B-cell lymphoma, supervised by Jean-Michel Dogne and Colette Chatelain.
Bouvy's research centers on thrombin generation dynamics, coagulation disorders, and women's health. Her work examines thrombin activity in postmenopausal women using estetrol, activated protein C resistance diagnostics, and anticoagulant monitoring techniques. She investigates how hormonal therapies impact hemostasis, metabolism, and bone health, with strong implications for cardiovascular risk assessment in aging women.
Her publication trends reveal consistent focus on thrombosis diagnostics (75% of research output), anticoagulant monitoring (66% of projects), and women's health applications (36% fingerprint concentration). Recent work emphasizes thrombin generation testing standardization and COVID-19-related coagulopathy investigations.
Scientific Recognition:
- Poster award (2015) for conference presentation
Bouvy actively participates in major research consortia including the Clinical Pharmacology Research Group (active since 2022) and COVILAB project (since 2020), contributing to 57 total research outputs including 22 articles, 25 posters, and 9 conference contributions. Her work receives consistent attention with 351 Scopus citations and 10 h-index.
She operates within the university's clinical pharmacology infrastructure, collaborating extensively on thrombosis diagnostics and anticoagulant monitoring projects, with particular focus on translating laboratory findings to clinical applications in women's health and pandemic response.
